✦ LIBER ✦

Will There Be a Vaccine to Protect Against the Hepatitis C Virus?

✍ Scribed by Benoît Callendret; Christopher M. Walker

Book ID: 119762160
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 436 KB
Volume: 142
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2012.02.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should Brazilian patients with chronic h

Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?

✍ Livia M Villar; Maria MM De Melo; Izabelle A Calado; Adilson J De Almeida; Elisa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Prospects for a vaccine against the hepa

Prospects for a vaccine against the hepatitis C virus

✍ Houghton, Michael; Abrignani, Sergio 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 206 KB

The challenge of developing a vaccine ag

The challenge of developing a vaccine against hepatitis C virus

✍ Xavier Forns; Jens Bukh; Robert H Purcell 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Development of duck hepatitis A virus ty

Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections

✍ Min-Chul Kim; Min-Jeong Kim; Yong-Kuk Kwon; A. Michael Lindberg; Seong-Joon Joh; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 240 KB

New vaccines offering a larger spectrum

New vaccines offering a larger spectrum of protection against acute otitis media: Will parents be willing to have their children immunized?

✍ Eve Dubé; Philippe De Wals; Vladimir Gilca; Nicole Boulianne; Manale Ouakki; Fra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Silibinin mode(s) of action against hepa

Silibinin mode(s) of action against hepatitis C virus: A controversy yet to be resolved

✍ Harel Dahari; Jeremie Guedj; Alan S. Perelson 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

I can hardly share the passionate enthusiasm of Breuhahn et al. for the ''dramatic'' improvements in understanding of molecular pathogenesis of hepatocellular carcinoma (HCC) and the claim for ''further rationally designed clinical trials based on molecular evidence''. 1 Among the causes of HCC, the